Literature DB >> 848529

Statistical analysis of first-trimester pregnancy terminations in an ambulatory surgical center.

N Bozorgi.   

Abstract

From June, 1973, to December, 1974, 12,219 women requested elective termination of pregnancy at the Concord Medical Center, a private outpatient clinic in Chicago, Illinois. Suction curettage with local anesthesia was performed for 10,890 of the women; the remaining 1,329 (10.9%) women were rejected for the following reasons: not pregnant, 1.9%; estimated duration of pregnancy over 12 weeks, 7.3% medical reasons, 1.6%; and other reasons, 0.1%. For the aborted patients, the immediate complication rate was 6.9 per 1,000. Complication rates were directly associated with length of gestation (whether determined on the basis of the patient-reported last menstrual period (LMP) or on the basis of the physical examination) and with the experience of the physicians. This study adds further evidence that first-trimester termination of pregnancy by suction curettage, with local anesthesia, in a nonhospital setting is a safe procedure when high medical standards are maintained.

Entities:  

Mesh:

Year:  1977        PMID: 848529     DOI: 10.1016/0002-9378(77)90254-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Comparison of complication rates in first trimester abortions performed by physician assistants and physicians.

Authors:  M A Freedman; D A Jillson; R R Coffin; L F Novick
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

2.  Physician knowledge of risks of surgical and invasive diagnostic procedures.

Authors:  S F Kronlund; W R Phillips
Journal:  West J Med       Date:  1985-04

3.  Estimating the costs of induced abortion in Uganda: a model-based analysis.

Authors:  Joseph B Babigumira; Andy Stergachis; David L Veenstra; Jacqueline S Gardner; Joseph Ngonzi; Peter Mukasa-Kivunike; Louis P Garrison
Journal:  BMC Public Health       Date:  2011-12-06       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.